Skip to main content

Executive Discovery

Strategy and Business Priorities

  1. What are the top strategic priorities for this year in lending operations? Internal note: Why we ask: aligns solution value to executive agenda. Good signal: explicit strategic linkage. Weak signal: initiative seen as optional experiment.
  2. Which outcomes matter most: speed, control assurance, cost reduction, or all three? Internal note: Why we ask: clarifies outcome hierarchy. Good signal: ranked priorities with measurable intent. Weak signal: broad objectives with no tradeoff.
  3. What should look materially better in six months? Internal note: Why we ask: sets near-term success criteria. Good signal: quantified goals. Weak signal: no measurable definition.

Decision and Funding Dynamics

  1. Is budget allocated for pilot and potential expansion? Internal note: Why we ask: determines execution probability. Good signal: budget line and owner exist. Weak signal: no funding pathway.
  2. Who is the executive sponsor and who must approve procurement? Internal note: Why we ask: maps buying committee. Good signal: clear decision chain. Weak signal: diffuse governance.
  3. Which stakeholders must be involved before a go/no-go decision? Internal note: Why we ask: avoids late-stage blockers. Good signal: list of required functions and owners. Weak signal: unknown dependencies.

Timeline Pressure and Triggers

  1. Are there regulatory deadlines, audit findings, or migration milestones influencing timing? Internal note: Why we ask: urgency often drives project velocity. Good signal: clear external trigger. Weak signal: no defined catalyst.
  2. What is the preferred timeline for pilot launch and decision checkpoint? Internal note: Why we ask: creates executable workback schedule. Good signal: specific target windows. Weak signal: open-ended timeline.
  3. What would cause this initiative to pause or be deprioritized? Internal note: Why we ask: surfaces risks early and honestly. Good signal: transparent constraints. Weak signal: hidden blockers.